$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 9 10 11 12 13 14 15 16 17 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2017 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Payment of Exercise | F | 31.12 | 1,910 | 59,439 | 23,139 | 25 K to 23.1 K (-7.63 %) |
| Feb 17 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 23.31 | 5,000 | 116,550 | 5,710 | |
| Feb 17 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Payment of Exercise | F | 31.12 | 3,294 | 102,509 | 39,728 | 43 K to 39.7 K (-7.66 %) |
| Feb 17 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 29.00 | 5,000 | 145,000 | 43,022 | 48 K to 43 K (-10.41 %) |
| Feb 17 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 23.31 | 5,000 | 116,550 | 48,022 | 43 K to 48 K (+11.62 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Option Exercise | A | 27.48 | 14,310 | 393,239 | 14,310 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | McEachron Kim | Chief People Office ... | Grant | A | 0.00 | 6,220 | 0 | 29,817 | 23.6 K to 29.8 K (+26.36 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Option Exercise | A | 27.48 | 12,170 | 334,432 | 12,170 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Grant | A | 0.00 | 5,290 | 0 | 19,777 | 14.5 K to 19.8 K (+36.52 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Option Exercise | A | 27.48 | 26,320 | 723,274 | 26,320 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Grant | A | 0.00 | 11,440 | 0 | 25,049 | 13.6 K to 25 K (+84.06 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | A | 27.48 | 56,120 | 1,542,178 | 56,120 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Grant | A | 0.00 | 8,140 | 0 | 44,022 | 35.9 K to 44 K (+22.69 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | A | 27.48 | 54,080 | 1,486,118 | 54,080 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Grant | A | 0.00 | 7,840 | 0 | 33,919 | 26.1 K to 33.9 K (+30.06 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | A | 27.48 | 46,790 | 1,285,789 | 46,790 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Grant | A | 0.00 | 6,780 | 0 | 333,987 | 327.2 K to 334 K (+2.07 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Option Exercise | A | 27.48 | 26,320 | 723,274 | 26,320 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Grant | A | 0.00 | 11,440 | 0 | 26,926 | 15.5 K to 26.9 K (+73.87 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | A | 27.48 | 191,500 | 5,262,420 | 191,500 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Grant | A | 0.00 | 27,760 | 0 | 87,380 | 59.6 K to 87.4 K (+46.56 %) |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Pla Frederic | Chief Bus & Prod De ... | Option Exercise | A | 27.48 | 56,120 | 1,542,178 | 56,120 | |
| Feb 02 2017 | GHDX | GENOMIC HEALTH INC | Pla Frederic | Chief Bus & Prod De ... | Grant | A | 0.00 | 8,140 | 0 | 34,582 | 26.4 K to 34.6 K (+30.78 %) |
| Jan 25 2017 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 23.31 | 5,000 | 116,550 | 25,000 | |
| Jan 25 2017 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 27.28 | 5,000 | 136,387 | 327,207 | 332.2 K to 327.2 K (-1.51 %) |
| Jan 25 2017 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 23.31 | 5,000 | 116,550 | 332,207 | 327.2 K to 332.2 K (+1.53 %) |
| Jan 12 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 23.31 | 5,000 | 116,550 | 10,710 | |
| Jan 12 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 29.22 | 5,000 | 146,087 | 35,882 | 40.9 K to 35.9 K (-12.23 %) |
| Jan 12 2017 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 23.31 | 5,000 | 116,550 | 40,882 | 35.9 K to 40.9 K (+13.93 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 319,993 | 319.3 K to 320 K (+0.21 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 11,350,328 | 11.3 M to 11.4 M (+0.01 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 1,759,659 | 1.8 M to 1.8 M (+0.04 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 33,385 | 32.7 K to 33.4 K (+2.08 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 194,044 | 193.4 K to 194 K (+0.35 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 29.39 | 680 | 19,985 | 214,308 | 213.6 K to 214.3 K (+0.32 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 29.39 | 340 | 9,993 | 8,512 | 8.2 K to 8.5 K (+4.16 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 29.39 | 340 | 9,993 | 4,291 | 4 K to 4.3 K (+8.61 %) |
| Jan 04 2017 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 29.39 | 340 | 9,993 | 65,578 | 65.2 K to 65.6 K (+0.52 %) |
| Dec 20 2016 | GHDX | GENOMIC HEALTH INC | Radford Jason W. | Chief Legal Officer | Payment of Exercise | F | 27.28 | 1,420 | 38,738 | 14,554 | 16 K to 14.6 K (-8.89 %) |
| Dec 20 2016 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Payment of Exercise | F | 27.00 | 1,066 | 28,782 | 13,241 | 14.3 K to 13.2 K (-7.45 %) |
| Dec 20 2016 | GHDX | GENOMIC HEALTH INC | Febbo Phillip G. | Chief Medical Offic ... | Payment of Exercise | F | 24.85 | 1,065 | 26,465 | 14,307 | 15.4 K to 14.3 K (-6.93 %) |
| Dec 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 23.31 | 5,000 | 116,550 | 15,710 | |
| Dec 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 30.61 | 5,000 | 153,030 | 35,882 | 40.9 K to 35.9 K (-12.23 %) |
| Dec 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 23.31 | 5,000 | 116,550 | 40,882 | 35.9 K to 40.9 K (+13.93 %) |
| Dec 06 2016 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 23.31 | 5,000 | 116,550 | 7,900 | |
| Dec 06 2016 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 30.02 | 5,000 | 150,100 | 59,620 | 64.6 K to 59.6 K (-7.74 %) |
| Dec 06 2016 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 23.31 | 5,000 | 116,550 | 64,620 | 59.6 K to 64.6 K (+8.39 %) |
| Nov 23 2016 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 31.73 | 3,468 | 110,056 | 14,331 | 17.8 K to 14.3 K (-19.48 %) |
| Nov 23 2016 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Sell | S | 31.73 | 3,600 | 114,211 | 17,799 | 21.4 K to 17.8 K (-16.82 %) |
| Nov 23 2016 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Buy | M | 17.41 | 3,600 | 62,676 | 21,399 | 17.8 K to 21.4 K (+20.23 %) |
| Nov 23 2016 | GHDX | GENOMIC HEALTH INC | Leber Laura | Chief Communication ... | Gift | G | 0.00 | 173 | 0 | 17,799 | 18 K to 17.8 K (-0.96 %) |
| Nov 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 18.89 | 1,673 | 31,603 | 0 | |
| Nov 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 18.89 | 3,327 | 62,847 | 1,673 | |
| Nov 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 32.42 | 1,673 | 54,235 | 327,207 | 328.9 K to 327.2 K (-0.51 %) |
| Nov 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 18.89 | 1,673 | 31,603 | 328,880 | 327.2 K to 328.9 K (+0.51 %) |
| Nov 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 31.36 | 3,327 | 104,334 | 327,207 | 330.5 K to 327.2 K (-1.01 %) |
| Nov 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 18.89 | 3,327 | 62,847 | 330,534 | 327.2 K to 330.5 K (+1.02 %) |
| Nov 10 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 23.31 | 5,000 | 116,550 | 20,710 | |
| Nov 10 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 29.68 | 5,000 | 148,422 | 35,426 | 40.4 K to 35.4 K (-12.37 %) |
| Nov 10 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 23.31 | 5,000 | 116,550 | 40,426 | 35.4 K to 40.4 K (+14.11 %) |
| Nov 07 2016 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 18.89 | 5,313 | 100,363 | 0 | |
| Nov 07 2016 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 1,050 | 0 | 200,851 | 201.9 K to 200.9 K (-0.52 %) |
| Nov 07 2016 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 1,100 | 0 | 201,901 | 203 K to 201.9 K (-0.54 %) |
| Nov 07 2016 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 28.88 | 5,313 | 153,423 | 59,620 | 64.9 K to 59.6 K (-8.18 %) |
| Nov 07 2016 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 18.89 | 5,313 | 100,363 | 64,933 | 59.6 K to 64.9 K (+8.91 %) |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 18.89 | 5,000 | 94,450 | 5,000 | |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 30.39 | 5,000 | 151,925 | 327,207 | 332.2 K to 327.2 K (-1.51 %) |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 18.89 | 5,000 | 94,450 | 332,207 | 327.2 K to 332.2 K (+1.53 %) |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 23.31 | 4,290 | 100,000 | 25,710 | |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 18.89 | 4,000 | 75,560 | 0 | |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 30.51 | 4,290 | 130,870 | 35,426 | 39.7 K to 35.4 K (-10.80 %) |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 23.31 | 4,290 | 100,000 | 39,716 | 35.4 K to 39.7 K (+12.11 %) |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 30.68 | 4,000 | 122,702 | 35,426 | 39.4 K to 35.4 K (-10.15 %) |
| Oct 12 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 18.89 | 4,000 | 75,560 | 39,426 | 35.4 K to 39.4 K (+11.29 %) |
| Oct 11 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 29.68 | 3,000 | 89,042 | 26,079 | 29.1 K to 26.1 K (-10.32 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 28.92 | 690 | 19,955 | 319,313 | 318.6 K to 319.3 K (+0.22 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 28.92 | 690 | 19,955 | 11,349,648 | 11.3 M to 11.3 M (+0.01 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 28.92 | 690 | 19,955 | 1,758,979 | 1.8 M to 1.8 M (+0.04 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 28.92 | 690 | 19,955 | 32,705 | 32 K to 32.7 K (+2.16 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 28.92 | 690 | 19,955 | 193,364 | 192.7 K to 193.4 K (+0.36 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 28.92 | 690 | 19,955 | 213,628 | 212.9 K to 213.6 K (+0.32 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 28.92 | 345 | 9,977 | 8,172 | 7.8 K to 8.2 K (+4.41 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 28.92 | 345 | 9,977 | 3,951 | 3.6 K to 4 K (+9.57 %) |
| Oct 04 2016 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 28.92 | 345 | 9,977 | 65,238 | 64.9 K to 65.2 K (+0.53 %) |
| Sep 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 18.89 | 5,000 | 94,450 | 10,000 | |
| Sep 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 26.83 | 5,000 | 134,156 | 327,207 | 332.2 K to 327.2 K (-1.51 %) |
| Sep 15 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 18.89 | 5,000 | 94,450 | 332,207 | 327.2 K to 332.2 K (+1.53 %) |
| Sep 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 18.89 | 4,000 | 75,560 | 4,000 | |
| Sep 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 27.41 | 4,000 | 109,637 | 35,426 | 39.4 K to 35.4 K (-10.15 %) |
| Sep 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 18.89 | 4,000 | 75,560 | 39,426 | 35.4 K to 39.4 K (+11.29 %) |
| Aug 25 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 18.89 | 5,000 | 94,450 | 15,000 | |
| Aug 25 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 27.24 | 5,000 | 136,215 | 327,207 | 332.2 K to 327.2 K (-1.51 %) |
| Aug 25 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 18.89 | 5,000 | 94,450 | 332,207 | 327.2 K to 332.2 K (+1.53 %) |
| Aug 15 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Buy | P | 27.02 | 89,896 | 2,428,621 | 11,348,958 | 11.3 M to 11.3 M (+0.80 %) |
| Aug 15 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Buy | P | 27.02 | 10,104 | 272,969 | 1,758,289 | 1.7 M to 1.8 M (+0.58 %) |
| Aug 15 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 18.89 | 5,000 | 94,450 | 8,000 | |
| Aug 15 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 28.87 | 5,000 | 144,374 | 35,426 | 40.4 K to 35.4 K (-12.37 %) |
| Aug 15 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 18.89 | 5,000 | 94,450 | 40,426 | 35.4 K to 40.4 K (+14.11 %) |
| Aug 10 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 28.74 | 3,000 | 86,222 | 29,079 | 32.1 K to 29.1 K (-9.35 %) |
| Jul 22 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 18.89 | 5,000 | 94,450 | 20,000 | |
| Jul 22 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 27.42 | 5,000 | 137,111 | 327,207 | 332.2 K to 327.2 K (-1.51 %) |
| Jul 22 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 18.89 | 5,000 | 94,450 | 332,207 | 327.2 K to 332.2 K (+1.53 %) |
| Jul 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 18.89 | 5,000 | 94,450 | 13,000 | |
| Jul 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 26.64 | 5,000 | 133,223 | 35,426 | 40.4 K to 35.4 K (-12.37 %) |
| Jul 08 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 18.89 | 5,000 | 94,450 | 40,426 | 35.4 K to 40.4 K (+14.11 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 26.74 | 746 | 19,948 | 318,623 | 317.9 K to 318.6 K (+0.23 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 26.74 | 746 | 19,948 | 11,259,062 | 11.3 M to 11.3 M (+0.01 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 26.74 | 746 | 19,948 | 1,748,185 | 1.7 M to 1.7 M (+0.04 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 26.74 | 746 | 19,948 | 32,015 | 31.3 K to 32 K (+2.39 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 26.74 | 746 | 19,948 | 192,674 | 191.9 K to 192.7 K (+0.39 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 26.74 | 746 | 19,948 | 212,938 | 212.2 K to 212.9 K (+0.35 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 26.74 | 373 | 9,974 | 7,827 | 7.5 K to 7.8 K (+5.00 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Grant | A | 26.74 | 373 | 9,974 | 3,606 | 3.2 K to 3.6 K (+11.54 %) |
| Jul 06 2016 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 26.74 | 373 | 9,974 | 64,893 | 64.5 K to 64.9 K (+0.58 %) |
| Jun 23 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 18.89 | 100 | 1,889 | 25,000 | |
| Jun 23 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Option Exercise | M | 18.89 | 4,900 | 92,561 | 25,100 | |
| Jun 23 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 26.67 | 100 | 2,667 | 327,207 | 327.3 K to 327.2 K (-0.03 %) |
| Jun 23 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Sell | S | 25.75 | 4,900 | 126,193 | 327,307 | 332.2 K to 327.3 K (-1.47 %) |
| Jun 23 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 18.89 | 100 | 1,889 | 332,207 | 332.1 K to 332.2 K (+0.03 %) |
| Jun 23 2016 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Scientific Of ... | Buy | M | 18.89 | 4,900 | 92,561 | 332,107 | 327.2 K to 332.1 K (+1.50 %) |
| Jun 23 2016 | GHDX | GENOMIC HEALTH INC | Parker Geoffrey M. | Director | Option Exercise | A | 26.07 | 20,000 | 521,400 | 20,000 | |
| Jun 14 2016 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | A | 26.18 | 10,000 | 261,800 | 10,000 | |
| Jun 14 2016 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | A | 26.18 | 10,000 | 261,800 | 10,000 | |
| Jun 14 2016 | GHDX | GENOMIC HEALTH INC | FUCHS HENRY J | Director | Option Exercise | A | 26.18 | 10,000 | 261,800 | 10,000 | |
| Jun 14 2016 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 26.18 | 10,000 | 261,800 | 10,000 | |
| Jun 13 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Option Exercise | A | 26.18 | 20,000 | 523,600 | 20,000 | |
| Jun 13 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 18.89 | 200 | 3,778 | 18,000 | |
| Jun 13 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 18.89 | 4,800 | 90,672 | 18,200 | |
| Jun 13 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 27.22 | 200 | 5,444 | 35,426 | 35.6 K to 35.4 K (-0.56 %) |
| Jun 13 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 26.60 | 4,800 | 127,674 | 35,626 | 40.4 K to 35.6 K (-11.87 %) |
| Jun 13 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 18.89 | 200 | 3,778 | 40,426 | 40.2 K to 40.4 K (+0.50 %) |
| Jun 13 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 18.89 | 4,800 | 90,672 | 40,226 | 35.4 K to 40.2 K (+13.55 %) |
| Jun 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Option Exercise | M | 18.89 | 1,997 | 37,723 | 0 | |
| Jun 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Sell | S | 28.00 | 1,997 | 55,916 | 32,079 | 34.1 K to 32.1 K (-5.86 %) |
| Jun 08 2016 | GHDX | GENOMIC HEALTH INC | Vaughn James J | Chief Commercial Of ... | Buy | M | 18.89 | 1,997 | 37,723 | 34,076 | 32.1 K to 34.1 K (+6.23 %) |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Option Exercise | M | 10.73 | 8,250 | 88,523 | 0 | |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Option Exercise | M | 10.73 | 8,250 | 88,523 | 0 | |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Option Exercise | M | 10.73 | 8,250 | 88,523 | 0 | |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Option Exercise | M | 10.73 | 8,250 | 88,523 | 0 | |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Option Exercise | M | 10.73 | 8,250 | 88,523 | 0 | |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Option Exercise | M | 10.73 | 8,250 | 88,523 | 0 | |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Buy | M | 10.73 | 8,250 | 88,523 | 317,877 | 309.6 K to 317.9 K (+2.66 %) |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Buy | M | 10.73 | 8,250 | 88,523 | 11,258,316 | 11.3 M to 11.3 M (+0.07 %) |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Buy | M | 10.73 | 8,250 | 88,523 | 1,747,439 | 1.7 M to 1.7 M (+0.47 %) |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Buy | M | 10.73 | 8,250 | 88,523 | 31,269 | 23 K to 31.3 K (+35.84 %) |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Buy | M | 10.73 | 8,250 | 88,523 | 191,928 | 183.7 K to 191.9 K (+4.49 %) |
| May 19 2016 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Buy | M | 10.73 | 8,250 | 88,523 | 212,192 | 203.9 K to 212.2 K (+4.05 %) |
| May 18 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 18.89 | 5,000 | 94,450 | 23,000 | |
| May 18 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 27.60 | 5,000 | 137,995 | 34,970 | 40 K to 35 K (-12.51 %) |
| May 18 2016 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 18.89 | 5,000 | 94,450 | 39,970 | 35 K to 40 K (+14.30 %) |